.svg){kind=icon}
HTA Accelerator
Get insights into payer decision making and evidence requirements to accelerate market access for your drug.
Infographic
Single Drug Assessment in 2022 vs 2021
Feb 10, 2023
The Health Technology Assessment (HTA) Accelerator from IQVIA lets you analyze past and current payer assessments and evidence requirements to guide clinical trial design and market access strategy across the product lifecycle.
Related solutions
Health Economics and Value
Access clearer, more compelling support to demonstrate the value of your product.
Real World & Health Data Sets
Richer real world data insights can drive smarter decisions.
Real World Evidence
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.